| PHL Code |
Test Name |
Test Comment |
Reference Range |
Specimen Requirements |
Set Up Schedule |
TAT |
CPT Code |
| 0290 |
ACID-FAST BACILLI, AMPLIFIED MYCOBACTERIUM TUBERCULOSIS DIRECT (MTD) |
Test performed when qualified by TB Control and Public Health Laboratory Guidelines. Not available as a routine test. |
By Report |
Properly collected sputum. |
Mon, Wed, Fri |
1-4 days |
87015, 87556 |
| 0101 |
ACID-FAST BACILLI CULTURE AND SMEAR |
Standard reference and fast track procedures are used for culturing and staining of all Mycobacteria. |
Smear: No acid-fast bacilli seen
Culture: No Mycobacterial species isolated |
Clinical specimen properly collected. Refrigerate. |
Daily, Mon-Sat |
Smear 1 day Culture 1-8 wks 8 wks –negative |
87206: Smear 87116, 87015 |
| 0102 |
ACID-FAST BACILLI IDENTIFICATION |
HPLC, nucleic acid probes and conventional methods are used for identification. Probes for M. tuberculosis complex, M. avium, M. intracellulare, M. gordonae and M. kansasii are available. |
By Report |
Pure culture |
HPLC: Mon, Th or: once weekly |
1-5 wks |
87206, 87116, 87118, 87015 |
| 0103 |
ACID-FAST BACILLI, PRIMARY DRUG SUSCEPTIBILITY PANEL BY BROTH FOR M. TUBERCULOSIS |
Panel includes: Isoniazid (INH), Ethambutol (EMB), Rifampin (RIF), and Streptomycin (SM) and Pyrazinamide (PZA) Call laboratory TB section to request drug susceptibilities for mycobacteria other than M. tuberculosis. |
[EIA Result Entry]![EIA Result] |
Pure culture |
Mon, Th |
2-3 wks |
87190: Ea drug |
| 0104 |
ACID-FAST BACILLI, PYRAZINAMIDE (PZA) SUSCEPTIBILITY TESTING BY BROTH FOR M. TUBERCULOSIS |
|
By report |
Pure culture |
Mon, Th |
2-3 wks |
87190: Ea drug |
| 0105 |
ACID-FAST BACILLI, CUSTOM DRUG SUSCEPTIBILITY PANEL BY BACTEC FOR MYCOBACTERIA |
|
By Report |
Pure culture |
Mon |
2-3 wks |
87190: Ea drug |
| 0106 |
ACID-FAST BACILLI, DRUG SUSCEPTIBILITY PANEL BY AGAR PROPORTION METHOD |
|
By Report |
Pure culture |
|
|
|
| 0107 |
ACID-FAST BACILLI SMEAR, “ONLY” |
Standard reference and fast track procedures are used for staining of all Mycobacteria. |
Smear: No acid-fast bacilli seen |
Clinical specimen properly collected. Refrigerate. |
Daily, Mon-Sat |
Smear 1 day |
87015, 87206: Smear |
| 0280 |
ADENOVIRUS CULTURE, SEE VIRAL CULTURE COMPREHENSIVE |
|
Negative |
Appropriate clinical specimen. (See Virology Information) |
Daily, Mon-Sat |
2 wks (negative) |
87252, 87253 |
| 0110 |
AEROBIC BACTERIAL CULTURE, ROUTINE |
All cultures are performed by standard reference bacterial procedures. Routine specimens other than stool (throat, sputum, skin, eyes etc.) are included. |
Normal flora |
Clinical specimen, properly collected and submitted in transport system. Refrigerate. |
Daily, Mon-Sat |
2 days (Negative) |
87077 |
| 0111 |
AEROBIC BACTERIAL CULTURE, SPECIAL |
Please indicate suspected organism(s) when submitting specimen. Listeria monocytogenes, Vibrio Cholerae Other |
None isolated |
Clinical specimen, properly collected and submitted in transport system. Refrigerate. If submitting inoculated culture media, hold at room temperature. |
Daily, Mon-Sat |
5 days 7 (Negative) |
87070 |
| 0113 |
AEROBIC BACTERIAL CULTURE, STOOL, CAMPYLOBACTER ONLY |
|
No Campylobacter species isolated |
1-2 gm of stool (size of thumbnail) in Para Pak container |
Daily, Mon-Sat |
4 days (Negative) |
87046 |
| 0114 |
AEROBIC BACTERIAL CULTURE, STOOL, SALMONELLA AND SHIGELLA ONLY |
|
No Salmonella or Shigella species isolated |
1-2 gm of stool (size of thumbnail) in Para Pak container |
Daily, Mon-Sat |
5 days (Negative) |
87045, 87046, 87077 |
| 0115 |
AEROBIC BACTERIAL CULTURE, STOOL, YERSINIA ENTEROCOLITICA ONLY |
|
No Yersinia enterocolitica isolated |
1-2 gm of stool (size of thumbnail) in Para Pak container |
Daily, Mon-Sat |
4 days (Negative) |
87046 |
| 0305 |
AEROBIC BACTERIAL CULTURE, STOOL, VIBRIO SPECIES ONLY |
|
No Vibrio species isolated |
1-2 gm of stool (size of thumbnail) in Para Pak container |
Daily, Mon-Sat |
4 days (Negative) |
87046, 87147, 87077 |
| 0118 |
AEROBIC BACTERIAL IDENTIFICATION |
|
By report |
Pure culture |
Daily, Mon-Sat |
5 days |
87077, 87147 |
| 0119 |
AEROBIC SUSCEPTIBILITY BY DISK DIFFUSION METHOD |
Studies performed on FDA approved drugs. |
By report |
Pure culture |
Daily, Mon-Sat |
2 days |
87184 |
| 0120 |
ANAEROBIC BACTERIAL CULTURE, ROUTINE |
|
No anaerobes isolated |
Clinical specimen properly collected and transported under anaerobic conditions |
Daily, Mon-Sat |
3 days (Negative) |
87075 |
| 0121 |
ANAEROBIC BACTERIAL IDENTIFICATION |
|
By report |
Pure culture |
Daily, Mon-Sat |
4 days |
87076 |
| 0122 |
ARBOVIRUS ANTIBODY PANEL, IFA, SERUM |
Serum is tested against antigens of St. Louis Encephalitis and Western Equine Encephalitis viruses. IgG titers of ≥16 suggest exposure, while the presence of IgM indicates recent infection. Incidence is seasonal from April to November. See specific arbovirus for individual testing. |
IgG <16 IgM <16 |
1 ml serum (minimum 0.2 ml) |
Tu, Th, Fri |
2 days |
86653, 86654 |
| 0123 |
ARBOVIRUS ANTIBODY PANEL, IFA, CSF |
|
IgG <1 IgM <1 |
1 ml CSF (minimum 0.2 ml) |
Tu, Th, Fri |
2 days |
86653, 86654 |
| 0129 |
BABESIOSIS DETECTION, BLOOD SMEAR (GIEMSA STAIN) |
|
None detected |
7 ml whole blood in EDTA (lavender top) tube. Submit to Laboratory within 24 hours or prepare 1 thick and 1 thin smear. |
Daily, Mon-Sat |
1 day |
87177, 88313 |
| 0290 |
BARTONELLA IgG ANTIBODY PANEL, IFA SERUM |
Bartonella henselae has been associated with cat scratch disease. Bartonella Quintana has been associated with trench fever. IgG crossreactivity between B. henselae and B. Quintana may occur. |
<64 |
1 ml serum (minimum 0.2 ml) |
Tu, Wed, Fri |
2-3 days |
86611 |
| 0131 |
BORDETELLA PERTUSSIS/PARAPERTUSSIS CULTURE AND DFA. |
DFA is performed on clinical specimens and reported as a preliminary result. Cultures on Regan Lowe agar are checked for up to 14 days before reporting no growth. |
DFA: Negative CULTURE: No B. pertussis/ parapertussis isolated. |
Nasopharyngeal swab submitted on Regan Lowe Medium. |
Daily, Mon-Sat |
Culture 14 days DFA 1 day |
87081; Cult, 87265, DFA, 87158 |
| 0132 |
BORDETELLA PERTUSSIS/PARAPERTUSSIS CULTURE |
Culture on Regan Lowe agar is checked for up to 14 days before reporting no growth. |
No B. pertussis/ parapertussis isolated. |
Nasopharyngeal swab submitted on Regan Lowe Medium. |
Daily, Mon-Sat |
14 days |
87081, 87158, 87077 |
| 0133 |
BORDETELLA PERTUSSIS/PARAPERTUSSIS ANTIGEN DETECTION, DFA |
|
Negative |
Nasopharyngeal swab in Regan Lowe Deep Medium or an air-dried and heat fixed smear for the DFA procedure. |
Daily, Mon-Sat |
1 day |
87265 |
| 0135 |
BRUCELLA IDENTIFICATION |
|
By report |
Pure culture |
Daily, Mon-Sat |
5-7 days |
87070 |
| 0138 |
CHLAMYDIA TRACHOMATIS CULTURE |
(For Medico-Legal Case) Specimens are plated after centrifugation onto cyclohexamide treated McCoy cell monolayers. Cultures are stained after 48 hours with polyclonal antisera for inclusion bodies characteristic of C. trachomatis. |
Negative |
Use M4-RT Transport Medium. Refrigerate Please transport to PHL within 24 hours on ice. |
Daily, Mon - Sat |
3 days |
87110, 87207 |
| 0140 |
CHLAMYDIA TRACHOMATIS, NUCLEIC ACID AMPLIFICATION, APTIMA Combo 2 Assay |
|
Negative |
Cervical or male urethral swab in APTIMA Combo 2 Assay Unisex Swab Specimen Collection Kit. 2 mL of mixed urine in the APTIMA Combo 2 urine specimen transport tube. Store and transport at 2° to 30°C. |
Daily, Mon-Sat |
3 days |
83898, 87491 |
| 0141 |
CLOSTRIDIUM BOTULINUM CULTURE |
|
No Clostridium botulinum isolated |
Clinical specimen properly collected. |
Daily, Mon-Sat |
5-12 days |
87075 |
| 0142 |
CLOSTRIDIUM BOTULINUM NEUTRALIZATION TEST |
|
Negative |
Call the Bioterrorism Response Unit for specimen requirements. |
Daily, Mon-Sat |
4 days Additional 24-48 hours if dialysis required. |
87001, 87230 |
| 0143 |
COCCIDIOIDES ANTIBODY, CF, SERUM |
All serum titers ≥4 should be considered presumptive evidence of coccidioidomycosis. Titers exceeding 16 usually reflect disseminated disease. In general, the higher the titer, the more severe the disease, and changes in serial titers are also of prognostic value. A negative CF test does not, however, rule out the diagnosis. Patients with cavitary disease are only 70% positive, and with nodular diseases, only 30% positive. |
<4 |
1 ml serum (minimum 0.2 ml) |
Th |
8 days |
86171 |
| 0144 |
COCCIDIOIDES AB, CF, CSF |
|
<1 |
1 ml CSF (minimum 0.2 ml) |
Th |
8 days |
86171 |
| 0145 |
COCCIDIOIDES AB, IgG AND IgM, EIA, SERUM |
A negative result with both IgM and IgG indicates that antibody for C. immitis antigen is either absent, below the level of detection of the assay or the specimen was obtained too early in the response. A positive result with either IgM or IgG implies the presence of antibody to C. immitis antigens. An early acute phase patient may only present an IgM response, while the chronic or convalescent patient may only present an IgG response. Reflex testing to the CF assay will be performed for those patients with history of anibody to Coccidioides antigen. |
≤0.149 |
1 ml serum (minimum 0.2 ml) |
Daily, Mon-Fri |
2 days |
86635(x2) |
| 0146 |
COCCIDIOIDES AB, IgG AND IgM, EIA, CSF |
|
≤0.149 |
1 ml CSF (minimum 0.2 ml) |
Mon-Fri |
2 days |
86635(x2) |
| 0147 |
CORYNEBACTERIUM DIPHTHERIAE CULTURE |
|
|
Call the Bacteriology Section for specific requirement |
Daily, Mon-Sat |
5 days 7 days (negative) |
87070 |
| |
COXSACKIE B ANTIBODY NEUTRALIZATION, SERUM |
|
By Report |
2 ml serum |
Mon-Fri |
3 wks |
86382 |
| 0148 |
CRYPTOSPORIDIUM/GIARDIA, STOOL, DFA |
This procedure is an in vitro DFA for the simultaneous detection of Cryptosporidium oocysts and Giardia cysts in fecal material. |
None detected |
Stool in 10% Formalin |
Daily, Mon-Sat |
1-2 days |
87272 |
| 0171 |
CRYPTOSPORIDIUM / ISOSPORA / CYCLOSPORA DETECTION, DIRECT STAIN (MODIFIED ACID FAST STAIN) |
|
None detected |
Stool in 10% Formalin |
Daily, Mon-Sat |
1-2 days |
87015, 87206 |
| 0149 |
CYSTICERCOSIS ANTIBODY, EIA, SERUM |
The relevance and significance of cysticercosis antibody levels is dependent on the clinical presentation of the patient. Only 50% of individuals with seizures and/or intracerebral calcifications test positive for serum cysticercosis antibodies, and usually none test positive for CSF cysticercosis antibodies. In contrast, cysticercosis antibodies are found in both serum and CSF from approximately 70% of patients with meningitis and 95% of patients with increased intracranial pressure. |
Negative ≤0.490 |
1 ml serum |
Daily, Mon-Fri |
2 days |
86682 |
| 0156 |
CYTOMEGALOVIRUS (CMV) CONVENTIONAL AND RAPID CULTURE |
|
Negative |
Appropriate specimen (See Virology Information) |
Daily, Mon-Sat |
4 wks (negative) |
87252 (x2), 87198, 87253 |
| 0157 |
E. COLI 0157:H7 SEROTYPING, SHIGA TOXIN POSITIVE STRAIN |
E. coli 0157:H7 has emerged as an enteric pathogen of public health importance, causing multiple outbreaks of hemorrhagic colitis, hemolytic uremic syndrome and diarrhea in nursing homes, day care centers, schools, and the community. One or two cytotoxins may be elaborated. Toxin producing E. coli of various serotypes has been reported so the syndrome is not limited to E. coli 0157:H7 |
None detected |
Pure culture of E. coli |
Daily, Mon-Sat |
4 – 14 days |
87046, 87147, 87335 |
| 0158 |
E. COLI 0157:H7, STOOL CULTURE SCREEN |
|
No E. coli:0157 isolated |
1 gram stool in Para Pak container |
Daily, Mon-Sat |
3 days |
87046 (x2) |
| 0159 |
E. COLI SHIGA TOXIN DETECTION |
|
None detected |
Pure culture of E. coli |
Daily, Mon-Sat |
3 days |
87147, 87335 |
| 0204 |
ECTOPARASITE IDENTIFICATION |
|
By report |
Place intact arthropod in a 15ml centrifuge tube. Seal cap securely. |
Daily, Mon-Sat |
1-2 days |
87168 |
| 0209 |
ENTAMOEBA HISTOLYTICA, EIA, STOOL |
The entamoeba histolytica test is an enzyme immunoassay for the rapid detection of the adhesin of E. histolytica in human fecal specimens. This test distinguishes E. histolytica from E. dispar whereby when diagnosis is made by light microscopy these protozoans are indistinguishable. |
Negative ≤ 0.490 |
Unpreserved stool specimen. Must be frozen if unable to deliver to the laboratory within 12 hours. |
Mon, Wed, Fri |
1-2 days |
87337 |
| 0162 |
ENTEROVIRUS TYPING |
|
By report |
Submit enterovirus isolate |
Mon-Fri |
3 wks |
87252, 87253, 87199 |
| 0163 |
EPIDEMIOLOGY: MOLECULAR STRAIN TYPING ANALYSIS USING PULSED-FIELD GEL ELECTROPHORESIS (PFGE) |
PFGE is used for the molecular strain typing of selective organisms. |
By report |
Consult with the Enteric Bacteriology Section before submitting specimens |
Mon |
Consult Molecular Epidemiology Section |
87152, 83891, 83892, 83894, 83912 |
| 0164 |
EPIDEMIOLOGY: DNA FINGERPRINTING OF MYCOBACTERIUM TUBERCULOSIS USING RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP) ANALYSIS |
DNA fingerprinting by RFLP has proven to be a valuable strain typing technique used for epidemiologic investigations of suspected outbreaks, reinfections vs. reactivation of infection, laboratory cross contaminations, and laboratory errors. |
By report |
Consult with the Molecular Epidemiology Section before submitting specimens |
Mon |
Consult Molecular Epidemiology Section |
87116, 87118, 83891, 83892, 83894, 83896, 83897, 83912 |
| 0297 |
FECAL COLIFORMS, WATER |
|
By report |
Consult with the Waters Section |
Mon-Fri |
2-3 days |
87999 |
| 0176 |
FUNGAL CULTURE AND IDENTIFICATION |
|
None isolated |
Properly collected clinical specimen |
Daily, Mon-Fri |
4 wks (Negative) 8 wks – if dimorphic fungus suspected |
87106, 87107, 87206, 87210 87015 – sputum 87176 – tissue |
| 0179 |
FUNGAL IDENTIFICATION |
|
By report |
Pure culture |
Daily, Mon-Fri |
Consult Mycology Lab |
87106 – yeast 87107 – mold |
|
FUNGAL IDENTIFICATION, DNA PROBE FOR COCCIDIOIDES IMMITIS OR HISTOPLASMA CAPSULATUM |
|
Negative |
Pure culture |
Mon |
7 days |
87797 |
| 0180 |
HAEMOPHILUS INFLUENZAE SEROTYPING (A-F), SLIDE AGGLUTINATION |
|
By report |
Pure culture on chocolate slant |
Daily, Mon-Sat |
5 days |
87147 |
| 0182 |
HEPATITIS A IgM ANTIBODY, EIA, SERUM |
A positive result indicates recent exposure to HAV. The IgM response will start approximately 2 months after exposure and continues to be measurable for up to 8 months after exposure. |
Negative |
1 ml serum (minimum 0.5 ml) |
T, Th |
4 days |
86709 |
| 0306 |
HEPATITIS A TOTAL ANTIBODY, EIA, SERUM |
The presence of anti-HAV is indicative of past or present infection with Hepatitis A Virus. Anti-HAV is detectable during the acute stage of illness (anti-HAV IgM) and may persist for years after recovery. The test for total anti-HAV is primarily used to determine previous exposure to Hepatitis A Virus and may be used to assess immune status. |
Nonreactive |
2.0 ml serum (minimum 1.5 ml) |
T, Th, Fri |
4 days |
86708 |
| 0183 |
HEPATITIS B CORE ANTIBODY, EIA, SERUM |
Hepatitis B core antibody (HBcAb) is present in serum after the appearance of hepatitis B surface antigen (HBsAg) and before the appearance of hepatitis B surface antibody (HBsAb). In the absence of HBsAg and HBsAb, HBcAb may be the only serologic marker of recent hepatitis B infection and potentially infectious blood. |
Nonreactive |
2 ml serum (minimum 1 ml) |
T, Wed, Th, Fri |
2 days (negative) |
86704 |
| 0184 |
HEPATITIS B SURFACE ANTIBODY, EIA, SERUM |
|
Nonreactive |
1 ml serum (minimum 0.5 ml) |
T, Wed, Th, Fri |
2 days |
86706 |
| 0185 |
HEPATITIS B SURFACE ANTIGEN, EIA, SERUM |
The hepatitis B surface antigen (HBsAG) is present in acute hepatitis B infection or in chronic carriers of hepatitis B. HBsAG becomes detectable after the incubation stage of the virus that generally lasts 4-12 weeks after exposure. |
Negative |
2.0 ml serum (minimum 1.5 ml) |
T, Wed, Th, Fri |
2 days (negative) |
87340 |
| 0190 |
HEPATITIS C ANTIBODY, EIA, SERUM |
|
Nonreactive |
2 ml serum |
T, Wed, Th, Fri |
2 days (negative |
86803 |
| 0196 |
HERPES SIMPLEX VIRUS (HSV), NON-GENITAL LESION SPECIMEN SOURCE OR FOR LEGAL ISSUES, CONVENTIONAL CULTURE |
|
Negative |
Appropriate specimen (See Virology Information) |
Daily, Mon-Sat |
14 days (negative) |
87207, 87252, 87253, 87273, 87274 |
| 0197 |
HERPES SIMPLEX VIRAL DNA (HSV) REAL-TIME PCR DETECTION |
|
Negative |
Appropriate specimen (See Virology Information) |
Daily, Mon-Fri |
1 day |
87273, 87274, 87801 |
| 0194 |
HERPES SIMPLEX VIRUS TYPE 2 (HSV-2), IgG, EIA, SERUM |
The HSV 2 assay is intended for the qualitative detection of the presence of absence of human IgG antibodies to HSV-2 in human sera. HSV-2 is primarily associated with genital and neonate infection. When the primary HSV-2 infection is clinical, the classical presentation is herpes genitalis, an infection characterized by bilaterally distributed lesions in the genital area accompanied by fever, inguinal lymphadenopathy and dysuria. HSV-2 infections cause approximately 85% of symptomatic primary genital HSV cases and 99% of recurrent genital herpes. |
Negative |
1 ml serum (minimum 0.25 ml) |
Mon |
8 days |
86696, 86695 |
| 0198 |
HISTOPLASMA ANTIBODY (YEAST AND MYCELIAL PHASE), CF, SERUM |
CF titers ³$8 are considered presumptive evidence of histoplasmosis, with the probability of infection rising with the height of the titer. Positive titers are also seen, however, with fungal disease other than histoplasmosis. Changing titers are useful both in diagnosis and in following a course of treatment. |
<8 |
1 ml serum (minimum 0.3 ml) |
Th |
8 days |
86698 |
| 0199 |
HISTOPLASMA ANTIBODY (YEAST AND MYCELIAL PHASE), CF, CSF |
|
<1 |
1 ml CSF (minimum 0.3 ml |
Th |
8 days |
86698 |
| 0293 |
HIV-1, ANTIBODY, WESTERN BLOT, ORAL FLUID |
|
Negative |
Requires special collection device. Contact HIV Serology Unit for information. 3.0 ml plasma (minimum) |
Daily, Mon-Sat |
3 days |
86689 |
| 0308 |
HIV-1 GENOTYPING |
Analysis of DNA sequence data to identify HIV-1 resistance associated mutations using the Bayer Health Care sequencing system; resistance associated mutations are based on current International AIDS Society-USA panel reporting recommendations. |
Wildtype HIV-1 DNA sequences |
3.0 ml plasma (minimum) Specimen must be collected in K3EDTA or Plasma Preparation Tubes (PPT). Separate plasma from whole blood within 4 hours or 2 hours for PPT tubes. For long-term storage freeze 1 ml aliquots at ≤ -20°C (preferably -70°C). Genotyping specimens must have a viral load of ≥1000 copies/ml. |
Daily, Mon-Fri |
14 days |
87901 |
| 0200 |
HIV-1 IgG ANTIBODY, WESTERN BLOT, SERUM |
|
Negative |
1 ml serum (minimum 0.25 ml) |
Daily, Mon-Sat |
3 days |
86689 |
| 0291 |
HIV-1 STANDARD, PCR, QUANTITATIVE VIRAL LOAD TEST |
An in vitro nucleic acid amplification of human immunodeficiency virus Type 1 (HIV-1) RNA in human plasma. The test is intended for use in prognosis procedures or to monitor the effects of therapy only. This is not a screening or diagnostic test for HIV infection. |
Lower limit of quantification: 400 copies/ml. Max. detection range: 750,000/ml. |
Specimen must be collected in K3EDTA. Separate plasma from whole blood within 6 hrs. Transfer plasma to sterile polypropylene tube. Store at -20° to -80° C. Deliver to lab within 5 days. Minimum 2 ml. |
Daily, Mon-Sat |
5 days |
87536 |
| 0292 |
HIV-1, SCREENING ANTIBODY, ELISA, ORAL FLUID |
|
Negative |
Requires special collection device. Contact HIV-Serology unit for information. |
Daily, Tu-Sat |
3 days |
86701 |
| 0202 |
HIV-1 SCREENING ANTIBODY, ELISA, SERUM |
Initial testing is done with ELISA techniques using a whole virus lysate antigen/ synthetic peptides. Positive sera are confirmed by the Western blot. |
Negative |
1 ml serum (minimum 0.1 ml) |
Daily, Mon-Fri |
3 days |
86701 |
| 0173 |
HIV-1 ULTRASENSITIVE PCR QUANTITATIVE VIRAL LOAD TEST |
An in vitro nucleic acid amplification of human immunodeficiency virus Type 1 (HIV-1) RNA in human plasma. The test is intended for use in prognosis procedures or to monitor the effects of therapy only. This is not a screening or diagnostic test for HIV infection. |
Lower limit of quantification: 50 copies/ml. Max: detection range: 100,000/ml. copies |
Specimen must be collected in K3EDTA. Separate plasma from whole blood within 6 hrs. Transfer plasma to sterile polypropylene tube. Store at -20 to -80° C. Deliver to lab within 5 days. Minimum 2 ml. |
Mon-Sat |
5 days |
87536 |
| 0207 |
LEAD |
Analysis on whole blood is done using the Graphite Furnace Atomic Absorption Spectrometry |
<10 ug/dl |
250 ul whole blood in EDTA for fingerstick 1 ml whole blood in EDTA or Heparin for venipunture. |
Daily, Mon-Fri |
3 days |
83655 |
| 0210 |
LEGIONELLA CULTURE AND DIRECT ANTIGEN DETECTION, DFA |
|
Negative |
Clinical specimen. Refrigerate |
Daily, Mon-Sat |
Culture 7 days DFA 1 day |
87081, 87140, 87205, 87206, 87278 |
| 0214 |
MEASLES (RUBEOLA), IgG AB, EIA, SERUM |
Available only for potential outbreak situations. Not a routine test. |
≤0.90 |
1 ml serum (minimum 0.25 ml) |
Daily, Mon-Fri |
2 days |
86765 |
| 0215 |
MEASLES (RUBEOLA) IgG AND IgM ANTIBODY PANEL, IFA, SERUM |
Available only for potential outbreak situations. Not a routine test. The traditional serologic diagnosis of measles requires a significant rise in antibody titer between acute and convalescent phase sera. However, the diagnosis can also be supported by demonstrating the presence of IgM antibody in a single specimen. Correct interpretation of serologic data depends upon the proper timing of specimen collection in relation to rash onset. This timing is especially important for interpreting negative IgM results since IgM antibody peaks approximately 10 days after exposure and may be undetectable 30 days after rash onset. Asymptomatic reinfection can occur in persons who have previously developed antibodies, whether from vaccination or from natural disease. Symptomatic reinfections are rare. These reinfections have been accompanied by rises in measles antibody titers. |
IgG: <8 IgM: <10 |
1 ml serum (minimum 0.25 ml) |
Daily, Mon-Fri |
2 days |
86765 |
| 0216 |
MEASLES (RUBEOLA) IgG ANTIBODY, IFA, IMMUNITY SCREEN, SERUM |
Available only for potential outbreak situations. Not a routine test. |
IgG: <8 IFA |
1 ml serum (minimum 0.25 ml) |
Daily, Mon-Fri |
2 days |
86765 |
| 0217 |
MEASLES (RUBEOLA) IgM ANTIBODY, IFA, SERUM |
Available only for potential outbreak situations. Not a routine test. |
<10 |
1 ml serum (minimum 0.25 ml |
Daily, Mon-Fri |
1 day |
86765 |
| 0150 |
MICROSPORIDIUM (MODIFIED TRICHROME STAIN) |
|
By report |
Stool in 10% Formalin |
Daily, Mon-Fri |
3 days |
87015, 87207 |
| 0227 |
NEISSERIA GONORRHOEAE CULTURE |
|
None isolated |
Properly inoculated MTM agar pill pocket plate. Incubate plates until transport. See specimen requirements. |
Daily, Mon-Sat |
3 days |
87081, 87140 |
| 0294 |
NEISSERIA GONORRHOEAE, NUCLEIC ACID AMPLIFICATION, APTIMA Combo 2 Assay. |
|
Negative |
Cervical or male urethral swab in APTIMA Combo 2 Assay Unisex Swab Specimen Collection Kit. 2 mL of mixed urine in the APTIMA Combe 2 urine specimen transport tube. Store and transport at 2° to 30°C. |
Daily, Mon- Fri |
3 days |
87591 |
| 0301 |
NEISSERIA GONORRHOEAE NAAT DETECTION |
Amplified-DNA probe test to screen for the presence of Neisseria gonorrhoeae from throat and rectal swab specimens. |
Negative |
Use swabs from the Aptima Vaginal swab specimen Collection Kit to collect throat or rectal specimen. Transport at room temperature within 30 days of collection. |
Mon - Fri |
3 days |
87591 |
| 0228 |
NEISSERIA MENINGITIDIS SEROGROUPING |
|
By report |
Pure culture on chocolate agar slant |
Daily, Mon-Sat |
1 day |
87077: Per serogroup |
| 0229 |
NOCARDIA CULTURE |
|
None isolated |
Properly collected clinical specimen |
Daily, Mon-Fri |
3 wks (negative) |
87077 |
| 0294 |
NOROVIRUS/VIRAL GASTROENTERITIS RT-PCR, STOOL |
|
By report |
Fresh stool collected in clean dry container, within 48-72 hours after onset of illness. Store at 4°C until delivered to the laboratory. |
Wednesday |
Consult Molecular Epidemiology Section |
83891, 83902, 83898, 83894, 83912 |
| 0231 |
OVA AND PARASITE EXAMINATION, BLOOD, LIGHT MICROSCOPY |
Giemsa stain examined for all blood parasites. |
By report |
Collect blood in 7ml EDTA (purple top) tube Submit to lab within 24 hours or prepare one thick and one thin smear, Giemsa stained or unstained. |
Daily, Mon-Sat |
1 day |
87205, 87207, 87177, 88313, 87015 |
| 0232 |
OVA AND PARASITE EXAMINATION, SPUTUM, LIGHT MICROSCOPY |
Direct examination of specimen for parasites |
By report |
Collect sputum in sterile 50 ml centrifuge tube. |
Daily, Mon-Sat |
2 days |
87205, 87207 |
| 0233 |
OVA AND PARASITE EXAMINATION, STOOL, LIGHT MICROSCOPY |
Trichrome stain and wet mount examined for intestinal parasites |
By report |
Stool preserved with ZN-PVA. Transfer fresh stool to fill line on PVA vial. Mix well. |
Daily, Mon-Sat |
2 days |
87177, 88313 |
| 0234 |
OVA AND PARASITE EXAMINATION, URINE, LIGHT MICROSCOPY |
Direct examination of urine sediment for parasites |
By report |
Collect first morning voided specimen in sterile 50 ml centrifuge tube. (minimum 15 ml) |
Daily, Mon-Sat |
2 days |
87177, 88313 |
| 0237 |
PINWORM PREPARATION, LIGHT MICROSCOPY |
Specimen is examined for the presence of Enterobius vermicularis. |
By report |
Swube or Scotch Tape slide preparation of perianal region |
Daily, Mon-Sat |
1-2 days |
87172 |
| 0239 |
POLIOVIRUS ANTIBODY, NEUTRALIZATION, SERUM |
This sensitive procedure is recommended for vaccine response testing and type-specific serodiagnosis of recent Poliovirus infection. |
By report |
1 ml serum (minimum 0.5 ml) |
Mon-Fri |
3 wks |
87252, 87253: Per Serotype |
| 0240 |
Q FEVER (COXIELLA BURNETTI) ANTIBODY, CF, SERUM |
|
<8 |
1 ml serum (minimum 0.1 ml) Acute and convalescent pair is recommended |
Th |
8 days |
86171 |
| 0241 |
RABIES EXAMINATION, BIOPSY |
Test includes the fluorescent examination of a specimen smear. |
Negative |
Properly collected biopsy specimen from brain or fresh animal head. |
Daily, Mon-Fri Weekends and after hours on emergencies |
1 day |
87205, 87207, 87003 |
| 0244 |
RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIGEN DETECTION, EIA |
|
Negative |
Swab, nasal aspirate. Do not dilute. |
Daily, Mon-Sat |
1 day |
87420 |
| 0248 |
RICKETTSIAL DISEASE ANTIBODY PANEL, IFA |
This panel includes IgG and IgM antigen specific titers against spotted fever group Rickettsia rickettsii (Rocky Mountain Spotted Fever), R. acari (Rickettsial pox) and the typhus fever group Rickettsia typhi (endemic or murine typhus), Rickettsia prowazeekii (epidemic typhus) and Brill-Zinsser disease caused by reactivation of latent R. prowazekii. |
IgG <64 IgM <64 |
1 ml serum or CSF (minimum 0.25 ml) |
Mon, Wed, Fri |
2 days |
86757 |
| 0254 |
ROTAVIRUS ANTIGEN DETECTION, EIA |
Rotaviruses are the major cause of epidemic viral gastroenteritis in infants and young children worldwide, with peak incidence between mid-December and mid-February. They are also associated with a severe sporadic gastroenteritis of infants and young children. |
Negative |
1gram stool or stick swab from diaper. Submit in sterile container; no preservatives. |
Daily, Mon-Sat |
1 day |
86759 |
| 0255 |
RPR (RAPID PLASMA REAGIN), SERUM |
The RPR test is a nontreponemal test to detect antibody reactive with lipoidal antigen of T. pallidum. Reactivity of the RPR test does not develop until 1-4 weeks after the appearance of the chancre. Nontreponemal tests are reactive in primary syphilis in 75-90% of cases. In secondary syphilis nearly 100% of cases are reactive with titers generally ³16. In untreated latent syphilis 70% of the cases are reactive. After adequate treatment of primary and secondary syphilis, there should be at least a four-fold decline in titer by 3 months. False positive RPR results occur in 1% to 2% of the normal population, after acute febrile illnesses, after immunizations or during pregnancy. Chronic false-positives are seen in autoimmune diseases (SLE), chronic infections and intravenous drug users. Generally these titers are £8. A reactive RPR result for routine specimens will be confirmed by reflexing to the treponemal antibody, TP-PA assay. |
Non-reactive |
1 ml serum (no CSF accepted) (minimum 0.25 ml) |
Daily, Mon-Sat |
1 day |
86592 |
| 0257 |
RUBELLA IgG AND IgM ANTIBODY PANEL, EIA, SERUM |
Available only for potential outbreak situations. Not a routine test. The detection of IgG antibodies suggests prior exposure to the virus, either natural or vaccine induced. The demonstration of IgM is valuable in detecting active or recent rubella infections. |
≤0.90 |
1 ml serum (minimum 0.3 ml) |
Tu, Th, Fri |
2 days |
See Each Assay |
| 0258 |
RUBELLA IgG ANTIBODY, EIA, SERUM |
Available only for potential outbreak situations. Not a routine test. |
≤0.90 |
1 ml serum (minimum 0.3 ml) |
Mon, Wed, Fri |
2 days |
86762 |
| 0259 |
RUBELLA IgM ANTIBODY, EIA, SERUM |
Available only for potential outbreak situations. Not a routine test. |
≤0.90 |
1 ml serum (minimum 0.3 ml) |
Tu, Th, Fri |
2 days |
86762 |
| 0260 |
SALMONELLA SEROGROUPING, GROUPS A-Z, 51-61 AND VI |
|
By report |
Pure culture on agar slant |
Daily, Mon-Sat |
4 days |
87147 |
| 0261 |
SALMONELLA SEROTYPING |
|
By report |
Pure culture on agar slant |
Daily, Mon-Sat |
4 days |
87147 |
| 0262 |
SHIGELLA SEROTYPING |
|
By report |
Pure culture on agar slant |
Daily, Mon-Sat |
4 days |
87147 |
| 0390 |
SPOLIGOTYPING, REVERSED LINE BLOT HYBRIDIZATION |
|
By report |
Consult with the Molecular Epidemiology Section before submitting specimens. |
Tu |
Consult Molecular Epidemiology Section |
87116, 87118, 83891, 83898, 83893, 83912 |
| 0220 |
TREPONEMAL ANTIBODY, TP-PA |
Treponema pallidum-Particle Agglutination (TP-PA) is a treponemal qualitative gelatin particle agglutination assay intended to be used for the detection of Treponema pallidum antibodies in human serum as an aid in the diagnosis of syphilis. It is based on the agglutination of colored gelatin particle carriers sensitized with T. pallidum (Nichols Strain) antigen. |
Non-reactive |
Collect blood in 7ml SST tube (tiger top) (Minimum 2 ml) |
Daily, Tu-Sat |
1 day |
86781 |
| 0271 |
TRICHOMONAS PREPARATION |
Test includes direct microscopic examination of specimen for motile trichomonads |
No trichomonads found |
Properly collected clinical specimen |
Daily, Mon-Sat |
1 day |
87210 |
| 0280 |
VARICELLA-ZOSTER VIRUS IgG AB, EIA SERUM |
Available only for potential outbreak situations. Not a routine test. |
<0.90 |
1 ml serum (minimum 0.25 ml) |
Daily, Mon-Fri |
1 day |
86787 |
| 0277 |
VARICELLA-ZOSTER VIRUS IgG ANTIBODY, IFA, SERUM |
Available only for potential outbreak situations. Not a routine test. |
<8 |
1 ml serum (minimum 0.25 ml) |
Daily, Mon-Fri |
1 day |
87290 |
| 0279 |
VARICELLA-ZOSTER VIRUS CULTURE |
|
Negative |
Appropriate clinical specimen. (See Virology Information) |
Daily, Mon-Sat |
2 wks (negative) |
87205, 87207, 87252, 87253 |
| 0280 |
VIRAL CULTURE COMPREHENSIVE |
|
Negative |
Appropriate clinical specimen. (See Virology Information) |
Daily, Mon-Sat |
2 wks (negative) |
87205, 87207, 87252, 87253 |
| 0281 |
VIRAL IDENTIFICATION |
|
By report |
Cell culture tube |
Daily, Mon-Sat |
1-2 wks |
87205, 87207, 87252, 87253 |
| 0291 |
WEST NILE VIRUS ANTIBODY, ELISA, SERUM |
West Nile Virus is a flavivirus, which can cause aseptic meningitis, meningoencephalitis, and encephalitis. Surveillance only. |
By report |
1 ml serum (minimum 0.5 ml) Refrigerate |
Consult Serology Section |
4 days |
86790 |
| 0292 |
WEST NILE VIRUS ANTIBODY, ELISA, CSF |
Surveillance only. |
By report |
1 ml CSF (minimum 0.5 ml) Frozen |
Consult Serology Section |
4 days |
86790 |
| 0311 |
WEST NILE VIRUS, RT-PCR, MOSQUITO POOLS |
|
Negative Ct values >37 |
Consult with the Molecular Epidemiology Section before submitting specimens. |
Mon |
Consult Molecular Epidemiology Section |
86790 |
| 0312 |
WEST NILE VIRUS, RT-PCR, TISSUE |
|
Negative Ct values >37 |
Consult with the Molecular Epidemiology Section before submitting specimens. |
Mon |
Consult Molecular Epidemiology Section |
86790 |
| 0288 |
WORM IDENTIFICATION, GROSS |
|
By report |
Place suspected worm or worm fragment from urine, stool or other clinical specimen in 50 ml centrifuge tube. Cover with water or saline. Seal lid securely. |
Daily, Mon-Sat |
1-2 days |
87169 |
| 0289 |
YERSINIA PESTIS (PLAGUE) ANTIBODY, SERUM, PHA/PHI |
Serum is screened by Passive Hemagglutination (PHA) and if positive confirmed by Passive Hemagglutination Inhibition (PHI). |
<10 |
1 ml serum (minimum 0.5 ml) |
Wed, Th, Fri |
3-4 days |
86280, 86793 |
